Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Remineralization potential of fluoride, amorphous calcium phosphate-casein phosphopeptide, and combination of hydroxylapatite and fluoride on enamel lesions: An in vitro comparative evaluation.

Bandekar S, Patil S, Dudulwar D, Moogi PP, Ghosh S, Kshirsagar S.

J Conserv Dent. 2019 May-Jun;22(3):305-309. doi: 10.4103/JCD.JCD_13_19.

2.

Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.

Advani K, Batra M, Tajpuriya S, Gupta R, Saraswat A, Nagar HD, Makwana L, Kshirsagar S, Kaul P, Ghosh AK, Pradhan S, Mehta A, Jaiswal A, Nakhate KT, Kamdi S.

J Obstet Gynaecol. 2020 Jan;40(1):96-101. doi: 10.1080/01443615.2019.1604644. Epub 2019 Jul 24.

PMID:
31339394
3.

Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study.

Deng R, Gibiansky L, Lu T, Agarwal P, Ding H, Li X, Kshirsagar S, Lu D, Li C, Girish S, Wang J, Boyer M, Humphrey K, Freise KJ, Salem AH, Seymour JF, Kater AP, Miles D.

Clin Pharmacokinet. 2019 Dec;58(12):1621-1634. doi: 10.1007/s40262-019-00788-8.

PMID:
31209657
4.

Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone.

Patel VJ, Joharapurkar AA, Kshirsagar SG, Sutariya BK, Patel MS, Bahekar RH, Jain MR.

Curr Mol Pharmacol. 2019;12(2):139-146. doi: 10.2174/1874467212666190212112402.

PMID:
30747091
5.

Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.

Jain M, Joharapurkar A, Patel V, Kshirsagar S, Sutariya B, Patel M, Patel H, Patel PR.

Eur J Pharmacol. 2019 Jan 15;843:113-120. doi: 10.1016/j.ejphar.2018.11.023. Epub 2018 Nov 17.

PMID:
30458168
6.

Relationships among classifications of ayurvedic medicine diagnostics for imbalances and western measures of psychological states: An exploratory study.

Mills PJ, Peterson CT, Wilson KL, Pung MA, Patel S, Weiss L, Kshirsagar SG, Tanzi RE, Chopra D.

J Ayurveda Integr Med. 2019 Jul - Sep;10(3):198-202. doi: 10.1016/j.jaim.2018.02.001. Epub 2018 Oct 29.

7.

Prevalence and Pattern of Phantom Ringing and Phantom Vibration among Medical Interns and their Relationship with Smartphone Use and Perceived Stress.

Mangot AG, Murthy VS, Kshirsagar SV, Deshmukh AH, Tembe DV.

Indian J Psychol Med. 2018 Sep-Oct;40(5):440-445. doi: 10.4103/IJPSYM.IJPSYM_141_18.

8.

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus.

Patel VJ, Joharapurkar AA, Kshirsagar SG, Sutariya BK, Patel MS, Patel HM, Pandey DK, Bahekar RH, Jain MR.

World J Diabetes. 2018 Jun 15;9(6):80-91. doi: 10.4239/wjd.v9.i6.80.

9.

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease.

Patel V, Joharapurkar A, Kshirsagar S, Patel M, Sutariya B, Patel H, Pandey D, Patel D, Ranvir R, Kadam S, Bahekar R, Jain M.

Can J Physiol Pharmacol. 2018 Jun;96(6):587-596. doi: 10.1139/cjpp-2017-0683. Epub 2018 Feb 6.

PMID:
29406832
10.

Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease.

Patel V, Joharapurkar A, Kshirsagar S, Sutariya B, Patel M, Patel H, Pandey D, Patel D, Ranvir R, Kadam S, Bahekar R, Jain M.

Cardiovasc Hematol Agents Med Chem. 2018;16(1):35-43. doi: 10.2174/1871525716666180118152158.

PMID:
29357809
11.

Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition.

Patel V, Joharapurkar A, Kshirsagar S, Sutariya B, Patel M, Pandey D, Patel H, Ranvir R, Kadam S, Patel D, Bahekar R, Jain M.

Chem Biol Interact. 2018 Feb 25;282:13-21. doi: 10.1016/j.cbi.2018.01.004. Epub 2018 Jan 8.

PMID:
29325849
12.

Central administration of coagonist of GLP-1 and glucagon receptors improves dyslipidemia.

Patel V, Joharapurkar A, Kshirsagar S, Sutariya B, Patel M, Patel H, Pandey D, Patel D, Bahekar R, Jain M.

Biomed Pharmacother. 2018 Feb;98:364-371. doi: 10.1016/j.biopha.2017.12.068. Epub 2017 Dec 27.

PMID:
29275178
13.

Balanced Coagonist of GLP-1 and Glucagon Receptors Corrects Dyslipidemia by Improving FGF21 Sensitivity in Hamster Model.

Patel V, Joharapurkar A, Kshirsagar S, Patel HM, Pandey D, Patel D, Sutariya B, Patel M, Bahekar R, Jain MR.

Drug Res (Stuttg). 2017 Dec;67(12):730-736. doi: 10.1055/s-0043-118808. Epub 2017 Sep 12.

14.

Sorghum husk biomass as a potential substrate for production of cellulolytic and xylanolytic enzymes by Nocardiopsis sp. KNU.

Kshirsagar SD, Bhalkar BN, Waghmare PR, Saratale GD, Saratale RG, Govindwar SP.

3 Biotech. 2017 Jul;7(3):163. doi: 10.1007/s13205-017-0800-z. Epub 2017 Jun 29.

15.

Intra-articular injections of ketamine and 25% dextrose improve clinical and pathological outcomes in the monosodium iodoacetate model of osteoarthritis.

Shetty YC, Patil AE, Jalgaonkar SV, Rege NN, Salgaonkar S, Teltumbde PA, Kshirsagar S, Koli PG, Brahma S.

J Basic Clin Physiol Pharmacol. 2017 Nov 27;28(6):543-553. doi: 10.1515/jbcpp-2016-0135.

PMID:
28593930
16.

Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes.

Alam SMK, Jasti S, Kshirsagar SK, Tannetta DS, Dragovic RA, Redman CW, Sargent IL, Hodes HC, Nauser TL, Fortes T, Filler AM, Behan K, Martin DR, Fields TA, Petroff BK, Petroff MG.

Reprod Sci. 2018 Feb;25(2):185-197. doi: 10.1177/1933719117707053. Epub 2017 May 8.

17.

ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.

Jain MR, Joharapurkar AA, Kshirsagar SG, Patel VJ, Bahekar RH, Patel HV, Jadav PA, Patel PR, Desai RC.

Br J Pharmacol. 2017 Jul;174(14):2346-2357. doi: 10.1111/bph.13842. Epub 2017 Jun 13.

18.

Central and Peripheral Glucagon Reduces Hyperlipidemia in Rats and Hamsters.

Patel V, Joharapurkar A, Kshirsagar S, Patel HM, Pandey D, Patel D, Shah K, Bahekar R, Shah GB, Jain MR.

Drug Res (Stuttg). 2017 Jun;67(6):318-326. doi: 10.1055/s-0043-102405. Epub 2017 Apr 26.

PMID:
28445900
19.

Preoperative Glycosylated Hemoglobin: A Risk Factor for Patients Undergoing Coronary Artery Bypass.

Narayan P, Kshirsagar SN, Mandal CK, Ghorai PA, Rao YM, Das D, Saha A, Chowdhury SR, Rupert E, Das M.

Ann Thorac Surg. 2017 Aug;104(2):606-612. doi: 10.1016/j.athoracsur.2016.12.020. Epub 2017 Mar 6.

PMID:
28274522
20.

Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones.

Chhajed SS, Chaskar S, Kshirsagar SK, Haldar GM, Kar Mahapatra D.

Comput Biol Chem. 2017 Apr;67:260-265. doi: 10.1016/j.compbiolchem.2017.02.004. Epub 2017 Feb 7.

PMID:
28193552
21.

Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent Model.

Patel H, Joharapurkar AA, Bahekar R, Patel P, Kshirsagar SG, Modi N, Ghoghari A, Patel VJ, Jain MR, Srinivas NR, Patel PR, Desai RC.

Drug Res (Stuttg). 2017 Apr;67(4):223-227. doi: 10.1055/s-0042-122776. Epub 2017 Feb 3.

PMID:
28158894
22.

Formulation and development of plasma volume expander using natural and modified starch from Solanum tuberosum.

Thombre NA, Vishwakarma AV, Jadhav TS, Kshirsagar SJ.

Int J Pharm Investig. 2016 Oct-Dec;6(4):207-217. doi: 10.4103/2230-973X.195930.

23.

Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia.

Patel H, Joharapurkar AA, Pandya VB, Patel VJ, Kshirsagar SG, Patel P, Gevriya B, Jain MR, Srinivas NR, Patel PR, Desai RC.

Xenobiotica. 2018 Jan;48(1):37-44. doi: 10.1080/00498254.2016.1278287. Epub 2017 Jan 19.

PMID:
28042744
24.

In-vivo bioavailability and lymphatic uptake evaluation of lipid nanoparticulates of darunavir.

Bhalekar MR, Upadhaya PG, Madgulkar AR, Kshirsagar SJ, Dube A, Bartakke US.

Drug Deliv. 2016 Sep;23(7):2581-2586. Epub 2015 May 21.

PMID:
25996834
25.

Ultrasound guided oblique subcostal transversus abdominis plane block: An observational study on a new and promising analgesic technique.

Mukherjee A, Guhabiswas R, Kshirsagar S, Rupert E.

Indian J Anaesth. 2016 Apr;60(4):284-6. doi: 10.4103/0019-5049.179468. No abstract available.

26.

Development and Validation of Stability-Indicating Method for Estimation of Chlorthalidone in Bulk and Tablets with the Use of Experimental Design in Forced Degradation Experiments.

Sonawane S, Jadhav S, Rahade P, Chhajed S, Kshirsagar S.

Scientifica (Cairo). 2016;2016:4286482. doi: 10.1155/2016/4286482. Epub 2016 Mar 31.

27.

Design, synthesis and molecular modeling studies of few chalcone analogues of benzimidazole for epidermal growth factor receptor inhibitor in search of useful anticancer agent.

Chhajed SS, Sonawane SS, Upasani CD, Kshirsagar SJ, Gupta PP.

Comput Biol Chem. 2016 Apr;61:138-44. doi: 10.1016/j.compbiolchem.2016.02.001. Epub 2016 Feb 6.

PMID:
26878127
28.

Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intake.

Patel V, Joharapurkar AA, Kshirsagar SG, Patel KN, Bahekar R, Shah G, Jain MR.

Can J Physiol Pharmacol. 2016 Feb;94(2):161-167. doi: 10.1139/cjpp-2014-0457. Epub 2015 Jul 29.

PMID:
26629909
29.

Formulation of mucoadhesive gastric retentive drug delivery using thiolated xyloglucan.

Bhalekar MR, Bargaje RV, Upadhaya PG, Madgulkar AR, Kshirsagar SJ.

Carbohydr Polym. 2016 Jan 20;136:537-42. doi: 10.1016/j.carbpol.2015.09.064. Epub 2015 Sep 25.

PMID:
26572385
30.

An isolated Amycolatopsis sp. GDS for cellulase and xylanase production using agricultural waste biomass.

Kshirsagar SD, Saratale GD, Saratale RG, Govindwar SP, Oh MK.

J Appl Microbiol. 2016 Jan;120(1):112-25. doi: 10.1111/jam.12988. Epub 2015 Dec 9.

31.

Median nerve schwannoma: A case and review of literature.

Padasali PS, Shankaregowda VS, Kshirsagar SD.

Asian J Neurosurg. 2015 Jul-Sep;10(3):212-5. doi: 10.4103/1793-5482.161178.

32.

Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia.

Jain MR, Joharapurkar AA, Pandya V, Patel V, Joshi J, Kshirsagar S, Patel K, Patel PR, Desai RC.

Drug Res (Stuttg). 2016 Feb;66(2):107-12. doi: 10.1055/s-0035-1554630. Epub 2015 Sep 14.

PMID:
26367279
33.

Design and development of SMEDDS for colon-specific drug delivery.

Bansode ST, Kshirsagar SJ, Madgulkar AR, Bhalekar MR, Bandivadekar MM.

Drug Dev Ind Pharm. 2016;42(4):611-23. doi: 10.3109/03639045.2015.1062510. Epub 2015 Jul 6.

PMID:
26146768
34.

Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.

Smith JA, Bourdet DL, Daniels OT, Ding YS, Gallezot JD, Henry S, Kim KH, Kshirsagar S, Martin WJ, Obedencio GP, Stangeland E, Tsuruda PR, Williams W, Carson RE, Patil ST.

Int J Neuropsychopharmacol. 2014 Dec 13;18(2). pii: pyu027. doi: 10.1093/ijnp/pyu027. Erratum in: Int J Neuropsychopharmacol. 2015 Apr;18(6). pii: pyv033. doi: 10.1093/ijnp/pyv033. Patil, D L [corrected to Bourdet, D L].

35.

Cellulolytic enzymes production by utilizing agricultural wastes under solid state fermentation and its application for biohydrogen production.

Saratale GD, Kshirsagar SD, Sampange VT, Saratale RG, Oh SE, Govindwar SP, Oh MK.

Appl Biochem Biotechnol. 2014 Dec;174(8):2801-17. doi: 10.1007/s12010-014-1227-1. Epub 2014 Nov 6.

PMID:
25374139
36.

Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.

Patel KN, Joharapurkar AA, Patel V, Kshirsagar SG, Bahekar R, Srivastava BK, Jain MR.

Can J Physiol Pharmacol. 2014 Dec;92(12):975-83. doi: 10.1139/cjpp-2014-0310. Epub 2014 Sep 29.

PMID:
25361428
37.

Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.

Kshirsagar S, Riedl M, Billing H, Tönshoff B, Thangavadivel S, Steuber C, Staude H, Wechselberger G, Edelbauer M.

J Immunol. 2014 Nov 15;193(10):4895-903. doi: 10.4049/jimmunol.1400044. Epub 2014 Oct 22.

38.

Therapeutic potential of coagonists of glucagon and GLP-1.

Patel VJ, Joharapurkar AA, Kshirsagar SG, Patel KN, Shah GB, Jain MR.

Cardiovasc Hematol Agents Med Chem. 2014;12(2):126-33. Review.

PMID:
25330114
39.

Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitor.

Jain MR, Joharapurkar AA, Bahekar RH, Patel H, Jadav P, Kshirsagar SG, Patel VJ, Patel KN, Ramanathan VK, Patel PR, Desai RC.

J Diabetes. 2015 Sep;7(5):708-17. doi: 10.1111/1753-0407.12233. Epub 2014 Dec 17.

PMID:
25327540
40.

Thyroid hormone modulates food intake and glycemia via ghrelin secretion in Zucker fatty rats.

Patel K, Joharapurkar A, Dhanesha N, Patel V, Kshirsagar S, Raval P, Raval S, Jain MR.

Drug Res (Stuttg). 2014 Oct;64(10):523-9. doi: 10.1055/s-0033-1363222. Epub 2013 Dec 19.

PMID:
24357139
41.

Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.

Patel V, Joharapurkar A, Dhanesha N, Kshirsagar S, Patel K, Bahekar R, Shah G, Jain M.

Can J Physiol Pharmacol. 2013 Dec;91(12):1009-15. doi: 10.1139/cjpp-2013-0189. Epub 2013 Jul 22.

PMID:
24289070
42.

Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.

Patel V, Joharapurkar A, Dhanesha N, Kshirsagar S, Detroja J, Patel K, Gandhi T, Patel K, Bahekar R, Jain M.

Pharmacol Rep. 2013;65(4):927-36.

43.

Enhanced activity of Akt in Teff cells from children with lupus nephritis is associated with reduced induction of tumor necrosis factor receptor-associated factor 6 and increased OX40 expression.

Kshirsagar S, Binder E, Riedl M, Wechselberger G, Steichen E, Edelbauer M.

Arthritis Rheum. 2013 Nov;65(11):2996-3006. doi: 10.1002/art.38089.

44.

Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db mice.

Dhanesha N, Joharapurkar A, Shah G, Kshirsagar S, Patel V, Patel K, Bahekar R, Jain M.

Eur J Pharmacol. 2013 Aug 15;714(1-3):188-92. doi: 10.1016/j.ejphar.2013.06.015. Epub 2013 Jun 25.

PMID:
23810686
45.

Design and development of liposomes for colon targeted drug delivery.

Gupta AS, Kshirsagar SJ, Bhalekar MR, Saldanha T.

J Drug Target. 2013 Feb;21(2):146-60. doi: 10.3109/1061186X.2012.734311.

PMID:
23373543
46.

Evaluation of wound healing activity of ferulic acid in diabetic rats.

Ghaisas MM, Kshirsagar SB, Sahane RS.

Int Wound J. 2014 Oct;11(5):523-32. doi: 10.1111/j.1742-481X.2012.01119.x. Epub 2012 Dec 12.

PMID:
23236955
47.

Immunomodulatory molecules are released from the first trimester and term placenta via exosomes.

Kshirsagar SK, Alam SM, Jasti S, Hodes H, Nauser T, Gilliam M, Billstrand C, Hunt JS, Petroff MG.

Placenta. 2012 Dec;33(12):982-90. doi: 10.1016/j.placenta.2012.10.005. Epub 2012 Oct 26.

48.

Statistical optimization of floating pulsatile drug delivery system for chronotherapy of hypertension.

Kshirsagar SJ, Patil SV, Bhalekar MR.

Int J Pharm Investig. 2011 Oct;1(4):207-13. doi: 10.4103/2230-973X.93005.

49.

Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.

Patel V, Joharapurkar A, Gandhi T, Patel K, Dhanesha N, Kshirsagar S, Dhote V, Detroja J, Bahekar R, Jain M.

J Diabetes. 2013 Jun;5(2):163-71. doi: 10.1111/j.1753-0407.2012.00227.x.

PMID:
22830490
50.

Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.

Dhanesha N, Joharapurkar A, Shah G, Dhote V, Kshirsagar S, Bahekar R, Jain M.

Pharmacol Rep. 2012;64(1):140-9.

Supplemental Content

Loading ...
Support Center